Biotech's movers for the week of August 10th and a preview of the week ahead
While the overall sector was flat this week, there were big movers on regulatory updates, including Inovio and Capricor. Meanwhile, AbCellera scored a big trial win while Sionna crashed after its cystic fibrosis therapy did not show additional benefit on top of Trikafta in a clinical trial.
5 hours ago
Epicrispr Biotechnologies closed a $90M series C on Tuesday to advance its epigenetic therapy toward pivotal studies in facioscapulohumeral muscular dystrophy (FSHD)
CEO Amber Salzman discusses the benefit of the raise, and contrasts the funding environment in biotech today versus previous years. Plus, she describes the unmet need in FSHD and how AI has already been helping the company understand the patient experience in its current clinical trial.
3 days ago
NVIDIA's Stacie Calad-Thomson discusses how AI is changing the physical world of biopharma - from automated labs to surgical devices and other robots
She believes we are in the early days of this type of work and that it will empower scientists, physicians and caregivers to focus on more important work that really matters.
3 days ago
.png){kind=logo}